Hepatitis A Virus Cellular Receptor 2
"Hepatitis A Virus Cellular Receptor 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An Ig domain-containing membrane receptor that is expressed by TH1 CELLS. It regulates the activation of MACROPHAGES and inhibits TH1-mediated auto- and alloimmune responses to promote IMMUNE TOLERANCE.
| Descriptor ID |
D000072597
|
| MeSH Number(s) |
D12.776.395.550.479 D12.776.543.550.437 D12.776.543.750.830.219
|
| Concept/Terms |
Hepatitis A Virus Cellular Receptor 2- Hepatitis A Virus Cellular Receptor 2
- CD366 Antigen
- Antigen, CD366
- T-Cell Immunoglobulin and Mucin Domain-Containing Protein 3
- T Cell Immunoglobulin and Mucin Domain Containing Protein 3
- TIMD3 Protein
- HAVCR2 Protein
- T-Cell Immunoglobulin Mucin Receptor 3
- T Cell Immunoglobulin Mucin Receptor 3
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis A Virus Cellular Receptor 2".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis A Virus Cellular Receptor 2".
This graph shows the total number of publications written about "Hepatitis A Virus Cellular Receptor 2" by people in this website by year, and whether "Hepatitis A Virus Cellular Receptor 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 5 | 1 | 6 |
| 2018 | 3 | 2 | 5 |
| 2019 | 2 | 0 | 2 |
| 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis A Virus Cellular Receptor 2" by people in Profiles.
-
HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study. Biomolecules. 2021 08 16; 11(8).
-
The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression. J Immunol. 2021 04 01; 206(7):1597-1608.
-
Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients. Microb Pathog. 2021 Apr; 153:104779.
-
Elevated plasma sTIM-3 levels in patients with severe COVID-19. J Allergy Clin Immunol. 2021 01; 147(1):92-98.
-
Storm of soluble immune checkpoints associated with disease severity of COVID-19. Signal Transduct Target Ther. 2020 09 07; 5(1):192.
-
Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease. Front Immunol. 2020; 11:1870.
-
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis. Clin Cancer Res. 2019 08 01; 25(15):4663-4673.
-
Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway. Exp Cell Res. 2019 03 15; 376(2):124-132.
-
Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients. Mediators Inflamm. 2018; 2018:1632902.
-
[Effect of Galectin-9/Tim-3 pathway on the polarization of M1/M2 subtype in murine macrophages induced by lipopolysaccharide]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Sep; 30(9):836-841.